Masayuki Mizui

3.9k citations
68 papers · 2.4k indexed · 1 hit paper · h-index 28

Masayuki Mizui

60 papers receiving 2.4k citations

Hit Papers

Pathogenesis of Human Systemic Lupus Erythematosus: A Cel...3172017202620202023100200300

Peers

Masayuki Mizui
Comparison fields: 5 of 97
  • Immunology 1.2k
  • Rheumatology 760
  • Nephrology 209
  • Cellular and Molecular Neuroscience 280
  • Oncology 381
Replace Violeta Rus with:
Violeta Rus United States
Marcia McDuffie United States
Weiqing Huang United States
Jacques Behmoaras United Kingdom
Elizabeth M. Kudlacz United States
Amanda Littlewood‐Evans Switzerland
Stefano Alivernini Italy
Mary M. Kavurma Australia
Masahide Yazaki Japan
Masayuki Mizui relative to Violeta Rus United States Violeta Rus's profile →
Citations per field
00.5×6.1×
Violeta Rus · 1×
Citations per year

Countries citing papers authored by Masayuki Mizui

Since Specialization
Citations

This map shows the geographic impact of Masayuki Mizui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Mizui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Mizui more than expected).

Fields of papers citing papers by Masayuki Mizui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Mizui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Mizui. The network helps show where Masayuki Mizui may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masayuki Mizui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masayuki Mizui Line = papers co-authored together Masayuki Mizui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20249
3 20240
4 20246
5 20242
6 20243
7 20241
8 20245
9 20240
10 20240
11 20242
12 20227
13 201912
14 201551
15 201521
16 201414
17 200859
18 200825
19 200625
20 200434

About Masayuki Mizui

Masayuki Mizui is a scholar working on Nephrology, Immunology and Transplantation, having authored 68 papers that have together received 2.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (15 papers), Systemic Lupus Erythematosus Research (13 papers), Axon Guidance and Neuronal Signaling (7 papers), Amino Acid Enzymes and Metabolism (6 papers), Renal Diseases and Glomerulopathies (6 papers), Renal and related cancers (5 papers) and Metabolism and Genetic Disorders (4 papers). The work is most often cited by research in Immunology (1.2k citations), Rheumatology (760 citations) and Nephrology (209 citations). Masayuki Mizui has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include George C. Tsokos, Tomohiro Koga, Abel Suárez‐Fueyo, Nobuya Yoshida, Hitoshi Kikutani, José C. Crispín, Hao Li, Esra Meidan, Vaishali R. Moulton and Yoshitaka Isaka. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026